RA
SRTA

Royce & Associates’s Strata Critical Medical Inc SRTA Stock Holding History

Royce & Associates’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8M Buy
2,816,372
+1,072,043
+61% +$5.16M 0.12% 279
2025
Q4 		$8.39M Buy
1,744,329
+703,086
+68% +$3.4M 0.09% 361
2025
Q3 		$5.27M Buy
1,041,243
+683,138
+191% +$3.02M 0.05% 461
2025
Q2 		$1.44M Sell
358,105
-134,038
-27% -$436K 0.01% 638
2025
Q1 		$1.34M Buy
492,143
+143
+0% +$513 0.01% 643
2024
Q4 		$2.09M Buy
+492,000
New +$1.87M 0.02% 625

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return